Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

ANGLE plc has "major breakthrough" for Parsortix

Andrew Newland, CEO of ANGLE plc (LON:AGL), tells Proactiveinvestors that the company has achieved a "major breakthrough" in the potential use of its Parsortix non-invasive cancer diagnostic product. Andrew discusses what it means for the company and what investors should now watch out for.
 
Meet Amryt Pharmaceuticals, Netscientific PLC, Anglo Asian Mining Plc and Oracle Coalfields Plc at our event, London, 12 May 2016. Register here »
no_picture_pai.jpg
Why Invest In ANGLE plc? Read More Here

Register here to be notified of future ANGLE plc articles
View full AGL profile

ANGLE plc Timeline

© Proactive Investors 2016

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.